Whittier Trust CO Amgen Inc Transaction History

Whittier Trust CO

$7.37 Billion
Q3 2024

A detailed history of Whittier Trust CO transactions in Amgen Inc stock. As of the latest transaction made, Whittier Trust CO holds 35,303 shares of AMGN stock, worth $9.3 Million. This represents 0.15% of its overall portfolio holdings.

Number of Shares

35,303

Previous 35,733 1.2%

Holding current value

$9.3 Million

Previous $11.2 Million 1.88%

% of portfolio

0.15%

Previous 0.16%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 21, 2024	SELL	$309.38 - $337.38 $133,033 - $145,073	-430 Reduced 1.2%	35,303 $11.4 Million
Q2 2024 Jul 26, 2024	SELL	$262.75 - $319.31 $557,030 - $676,937	-2,120 Reduced 5.6%	35,733 $11.2 Million
Q1 2024 May 02, 2024	SELL	$268.87 - $324.56 $357,328 - $431,340	-1,329 Reduced 3.39%	37,853 $10.8 Million
Q4 2023 Jan 11, 2024	BUY	$255.7 - $288.46 $402,727 - $454,324	1,575 Added 4.19%	39,182 $11.3 Million
Q3 2023 Oct 27, 2023	SELL	$218.65 - $271.46 $139,936 - $173,734	-640 Reduced 1.67%	37,607 $10.1 Million
Q2 2023 Jul 24, 2023	SELL	$214.27 - $253.37 $432,825 - $511,807	-2,020 Reduced 5.02%	38,247 $8.49 Million
Q1 2023 Apr 21, 2023	SELL	$225.79 - $275.2 $50,802 - $61,920	-225 Reduced 0.56%	40,267 $9.73 Million
Q4 2022 Jan 25, 2023	BUY	$229.03 - $291.01 $136,959 - $174,023	598 Added 1.5%	40,492 $0
Q3 2022 Oct 21, 2022	SELL	$224.46 - $253.15 $70,480 - $79,489	-314 Reduced 0.78%	39,894 $8.99 Million
Q2 2022 Jul 28, 2022	SELL	$230.71 - $256.74 $62,291 - $69,319	-270 Reduced 0.67%	40,208 $9.78 Million
Q1 2022 Apr 29, 2022	BUY	$219.27 - $242.57 $554,095 - $612,974	2,527 Added 6.66%	40,478 $9.79 Million
Q4 2021 Jan 19, 2022	BUY	$198.88 - $227.6 $1,193 - $1,365	6 Added 0.02%	37,951 $8.54 Million
Q3 2021 Nov 01, 2021	SELL	$212.27 - $248.7 $36,085 - $42,279	-170 Reduced 0.45%	37,945 $8.07 Million
Q2 2021 Jul 29, 2021	BUY	$233.58 - $259.14 $858,640 - $952,598	3,676 Added 10.67%	38,115 $9.29 Million
Q1 2021 Apr 26, 2021	BUY	$221.91 - $258.6 $2.12 Million - $2.47 Million	9,548 Added 38.36%	34,439 $8.57 Million
Q4 2020 Jan 29, 2021	SELL	$216.38 - $257.67 $30,293 - $36,073	-140 Reduced 0.56%	24,891 $5.72 Million
Q3 2020 Oct 30, 2020	SELL	$234.65 - $260.95 $124,833 - $138,825	-532 Reduced 2.08%	25,031 $6.36 Million
Q2 2020 Jul 10, 2020	SELL	$197.81 - $242.74 $162,006 - $198,804	-819 Reduced 3.1%	25,563 $6.03 Million
Q1 2020 Apr 27, 2020	SELL	$182.24 - $241.7 $1.74 Million - $2.31 Million	-9,542 Reduced 26.56%	26,382 $5.35 Million
Q4 2019 Jan 31, 2020	BUY	$189.21 - $243.2 $118,445 - $152,243	626 Added 1.77%	35,924 $8.66 Million
Q3 2019 Oct 18, 2019	BUY	$174.11 - $208.62 $233,481 - $279,759	1,341 Added 3.95%	35,298 $6.83 Million
Q2 2019 Jul 23, 2019	BUY	$166.7 - $195.41 $75,015 - $87,934	450 Added 1.34%	33,957 $6.26 Million
Q1 2019 Apr 29, 2019	SELL	$180.87 - $203.88 $56,069 - $63,202	-310 Reduced 0.92%	33,507 $6.37 Million
Q4 2018 Feb 07, 2019	BUY	$178.4 - $208.25 $8,384 - $9,787	47 Added 0.14%	33,817 $6.58 Million
Q3 2018 Oct 23, 2018	SELL	$185.29 - $208.89 $61,330 - $69,142	-331 Reduced 0.97%	33,770 $7 Million
Q2 2018 Jul 27, 2018	BUY	$166.05 - $186.51 $3.19 Million - $3.59 Million	19,226 Added 129.25%	34,101 $6.29 Million
Q2 2018 Jul 20, 2018	SELL	$166.05 - $186.51 $3.25 Million - $3.65 Million	-19,552 Reduced 56.79%	14,875 $1.76 Million
Q1 2018 May 01, 2018	BUY	$169.43 - $198.0 $32,699 - $38,214	193 Added 0.56%	34,427 $5.87 Million
Q4 2017 Feb 07, 2018	BUY	$168.79 - $188.59 $2,531 - $2,828	15 Added 0.04%	34,234 $5.95 Million
Q3 2017 Oct 23, 2017	BUY	$167.29 - $191.0 $5.72 Million - $6.54 Million	34,219	34,219 $6.38 Million

Others Institutions Holding AMGN

# of Institutions

3,125

Shares Held

409M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $141B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Whittier Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Whittier Trust CO with notifications on news.

Account

Whittier Trust CO Amgen Inc Transaction History